Asahi Kasei Medical
  • Site Map
  • Contact Us
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Home
  • Our Approach to Business
  • Corporate Information
  • News
  • Products
  • Patients and Families

Leukocytapheresis (LCAP)

About Leukocytapheresis (LCAP)

A treatment to remove over-active leukocytes (white blood cells) from the blood

In leukocytapheresis (LCAP), blood is circulated outside the body and passed through a filter that traps activated leukocytes; then the blood is returned to the body. This therapy is indicated for inflammatory bowel disease, including ulcerative colitis (UC) and Crohn’s disease, as well as rheumatoid arthritis.

Leukocytapheresis (LCAP) treatment diagram

Contact Us

Please feel free to send us any questions you may have about our products and support.

Contact Us
We are restricted by law from replying to inquiries regarding the therapeutic effects or side effects of therapeutic methods or our products. Please consult with your healthcare provider or a medical institution.

Top of page